Skip to main content
. 2022 Mar 5;44(4):1941–1960. doi: 10.1007/s11357-022-00536-0

Table 2.

Primers and TaqMan miRNA assays

Target gene Forward Reverse
ADIPOQ GAGATGGACGGACGGAGTCCTTTAGG CTGGTCATGTTTGTGAAGCTCCC
β-actin TGAGAGGGAAATCGTGCGTG TGCTTGCTGATCCACATCTGC
CD206 TATGGAATAAAGACCCGCTGAC TGCTCATGTATCTCTGTGATGCT
GAPDH GGCACAGTCAAGGCTGAGAATG ATGGTGGTGAAGACGCCAGTA
GLUT4 CATTCCTTGGTTCATCGTG ATAGCCTCCGCAACATAC
IL-1β AGATGATAAGCCCACTCTACAG ACATTCAGCACAGGACTCTC
IL-6 TGCAATAACCACCCCTGACC GTGCCCATGCTACATTTGCC
IL-8 GGACAAGAGCCAGGAAGAAA CCTACAACAGACCCACACAATA
IL-10 AGGCATTCTTCACCTGCTCC AAGACCCAGACATCAAGGCG
MCP1 GGCTGAGACTAACCCAGAAAAG GGGTAGAAACTGTGGTTCAAGAG
NF-kB ACAGCTGGATGTGTGACTGG TCCTCCGAAGCTGGACAAAC
p21 CCATCCCTCCCCAGTTCATT AAGACAACTACTCCCAGCCC
SIRT1 TGTTTCCTGTGGGATACCTGA TGAAGAATGGTCTTGGGTCTTT
TNF-α AAGCCTGTAGCCCACGTGTA GGCACCACTAGTTGGTGGTCTTTG
TGF-b CCCAGCATCTGCAAAGCT GTCAATGTACAGCTGCCGCA
IL-1α CTTTCCCTGCCTGACCTTATT GAATGAAGCTACTGCCCTACTC
PPAR-g TGTGGGGATAAAGCATCAGGC CCGGCAGTTAAGATCACACCTAT
CD163 ACTGCAAGAACTGGCAATGG CCATGCTTCACTTCAACAGG
TaqMan assay ID
miR-21 ID00397
miR-146a ID000468
RNU44 ID001094